| Literature DB >> 29561788 |
Maria Ángeles Pérez-Albacete Martínez1, Carlos Pérez-Albacete Martínez2, José Eduardo Maté Sánchez De Val3, María Luisa Ramos Oltra4, Manuel Fernández Domínguez5, Jose Luis Calvo Guirado6.
Abstract
The aim of this study was to evaluate osseointegration and crestal bone height in implants with a triangular cervical design in comparison with a standard rounded cervical design. The control group consisted of 24 implants with a standard cervical design, and the test group of 24 implants with a triangular cervical design. The implants were inserted in healed bone in six American Foxhounds. Crestal bone height and tissue thickness in the cervical portion were measured after 12 weeks healing. Data analysis found mean crestal bone loss of: 0.31 ± 0.24 mm on the buccal side, 0.35 ± 0.14 mm on the lingual in the test group, and 0.71 ± 0.28 mm buccal loss, and 0.42 ± 0.30 mm lingual in the control group; with statistically significant differences on the buccal aspect (p = 0.0019). Mean tissue thickness in the test group was 1.98 ± 0.17 mm on the buccal aspect, and 2.43 ± 0.93 mm in the lingual; in the control group it was 2.48 ± 0.61 mm buccal thickness, and 2.88 ± 0.14 mm lingual, with significant differences on both aspects (p = 0.0043; p = 0.0029). The results suggest that greater thickness of peri-implant tissue can be expected when the triangular cervical implant design is used rather than the standard cervical design.Entities:
Keywords: bone-to-implant contact; crestal bone loss; new implant design
Year: 2018 PMID: 29561788 PMCID: PMC5951308 DOI: 10.3390/ma11040462
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1Implant designs compared in the study: C1® implant (a) and V3® implant (b).
Figure 2The implantation protocol was 4 implants per hemi-mandible.
Figure 3Each hemi-mandible received four tapered implants positioned at crestal bone level.
Figure 4Linear measurements to assess peri-implant bone remodeling and peri-implant soft tissue remodeling. IS: implant shoulder; C: first bone-to-implant contact; IS´: implant surface; E: the most external portion of the epithelium.
ISQ analysis and measurements at baseline and 12 weeks. Results presented as mean values and medians. A Friedman test was applied for inter-group comparisons. (p < 0.05); * indicates statistically significant differences (<0.05).
| ISQ Values | Baseline | 12 Weeks | |||
|---|---|---|---|---|---|
| Mean ± SD | Median | Mean ± SD | Median | ||
| Implants C1® (Control group) | 69.56 ± 3.17 | 69.91 | 70.35 ± 3.42 | 71.35 | 0.17 |
| Implants V3® (Test group) | 73.82 ± 2.78 | 70.79 | 74.02 ± 3.96 | 74.56 | 0.21 |
| 0.048 * | – | 0.041 * | – | – | |
Bone-level changes between baseline and 12-week study times (measured from the top of the implant collar (line IS) to the first point of bone-to-implant contact (line C)). Marginal bone loss (mean ± SD); * indicates significant differences (p < 0.05).
| 12 WEEKS | IS-C | |
|---|---|---|
| BUCCAL | LINGUAL | |
| Implants C1® (Control group) | 0.71 ± 0.28 mm | 0.42 ± 0.30 mm |
| Implants V3® (Test group) | 0.31 ± 0.24 mm | 0.35 ± 0.14 mm |
| 0.0019 * | 0.132 | |
Tissue thickness changes between baseline and 12-week study times (measured from the top of the implant shoulder (line IS’) to the most external portion of the tissue (line E)). Tissue thickness loss (mean ± SD); * indicates significant differences (p < 0.05).
| 12 WEEKS | IS’-E | |
|---|---|---|
| BUCCAL | LINGUAL | |
| Implants V3® (Test group) | 1.98 ± 0.17 mm | 2.43 ± 0.93 mm |
| Implants C1® (Control group) | 2.48 ± 0.61 mm | 2.88 ± 0.14 mm |
| 0.0043 * | 0.0029 * | |
Figure 5Marginal bone-level changes between baseline and 12-week study times. Marginal bone loss (mean ± SD); * indicates significant differences (p < 0.05).
Figure 6Tissue thickness changes between baseline and 12-week study times. Tissue thickness loss (mean ± SD); * indicates significant differences (p < 0.05).